The 18-month publication provisions of the American Inventors Protection Act of 1999 will take effect later this year 1. With certain exceptions, any patent application filed or pending in the US on ...
The National Committee on Biosafety of the Philippines (NCBP) and the Advanced Science and Technology Institute (ASTI) held ...
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN), a global, clinical-stage biotechnology company developing and manufacturing novel therapies, announced today the submission ...
PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and commercialization ...
BEIJING, Nov. 15, 2021 /PRNewswire/ -- HebaBiz Biotech is pleased to announce that in November 2021, the Center for Drug Evaluation (CDE) of The National Medical Products Administration (NMPA) of ...
This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the ...
Dublin, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The "Applications of Nanoparticles in the Pharmaceutical and Biomedical Industries Training Course (Nov 12th - Nov 13th, 2025)" has been added to ...
GlaxoSmithKline (GSK) today announced the submission of a new drug application to the US Food and Drug Administration and new data from two Phase III trials for Rezonic TM /Zunrisa TM (casopitant), a ...
LONDON--(BUSINESS WIRE)--According to a recent Technavio report, the blue biotechnology market is expected to grow by USD 1.77 billion during 2019-2023. Growth in the blue biotechnology market can be ...
Chitinases are specialised enzymes that catalyse the degradation of chitin, one of the most abundant natural polysaccharides. Found across diverse biological domains, these enzymes play crucial roles ...
PRINCETON, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or Company), a clinical-stage immunotherapy company developing a growing pipeline of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback